These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13216816)

  • 1. Observations on the nature of the neuromuscular block in myasthenia gravis.
    HARVEY AM; GROB D; JOHNS RJ
    Trans Assoc Am Physicians; 1954; 67():94-6. PubMed ID: 13216816
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular transmission with a note on myasthenia gravis.
    MEAD JC
    McGill Med J; 1957 Apr; 26(2):88-95. PubMed ID: 13429923
    [No Abstract]   [Full Text] [Related]  

  • 3. An electrophysiologic study of the neuromuscular junction in myasthenia gravis.
    DAHLBACK O; ELMQVIST D; JOHNS TR; RADNER S; THESLEFF S
    J Physiol; 1961 Apr; 156(2):336-43. PubMed ID: 13719322
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis.
    GROB D; HARVEY AM; JOHNS RJ
    Bull Johns Hopkins Hosp; 1956 Sep; 99(3):125-35. PubMed ID: 13364528
    [No Abstract]   [Full Text] [Related]  

  • 5. Motor end plate changes in myasthenia gravis.
    CHURCHILL-DAVIDSON HC
    Am J Phys Med; 1959 Aug; 38():159-62. PubMed ID: 13810230
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuromuscular transmission in myasthenia gravis.
    CHURCHILL-DAVIDSON HC; RICHARDSON AT
    J Physiol; 1953 Nov; 122(2):252-63. PubMed ID: 13118536
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the nature of the neuromuscular block in myasthenia gravis.
    GROB D; JOHNS RJ; HARVEY AM
    Trans Assoc Am Physicians; 1955; 68():50-3. PubMed ID: 13299310
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenic investigations on myasthenia and myotonia with special reference to therapy. II. Effect of blood serum isolated in myotonia on nerve-muscle preparation in frog].
    KURES H; MALEK P
    Cas Lek Cesk; 1952 Jun; 91(24-25):709-11. PubMed ID: 14390261
    [No Abstract]   [Full Text] [Related]  

  • 9. Myasthenia gravis. III. Lack of inhibitory action of fractionated thymus extracts.
    ZACKS SI
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):574-5. PubMed ID: 13614427
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenesis of partial neuromuscular block in experimental myasthenia gravis].
    Kalden JR
    Verh Dtsch Ges Inn Med; 1973; 79():588-9. PubMed ID: 4790302
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed increase of neuromuscular block in a series of faradizations of the motor nerve in myasthenic patients.
    DESMEDT JE
    J Physiol; 1958 Jan; 140(1):3-4P. PubMed ID: 13514660
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia].
    Bouhour F; Confavreux C
    Rev Prat; 2005 Nov; 55(17):1927-32. PubMed ID: 16396237
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular transmission in myasthenia gravis.
    CHURCHILL-DAVIDSON HC; RICHARDSON AT
    Am J Med; 1955 Nov; 19(5):691-2. PubMed ID: 13268465
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular pharmacology.
    Karczmar AG
    Annu Rev Pharmacol; 1967; 7():241-76. PubMed ID: 5337082
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
    Gehi A; Benatar M; Langberg J
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in neuromuscular transmission in myasthenia gravis as determined by studies of drug action.
    GROB D; JOHNS RJ; HARVEY AM
    Am J Med; 1955 Nov; 19(5):684-90. PubMed ID: 13268464
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients.
    Rostedt A; Padua L; Stålberg EV
    Clin Neurophysiol; 2005 Sep; 116(9):2058-64. PubMed ID: 16043394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenic crisis and cholinergic crisis].
    SHIGEZAI T
    Sogo Igaku; 1961 Oct; 18():665-9. PubMed ID: 13911880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.